Literature DB >> 9506463

Activation of human monocytes by LPS and DHEA.

A D Delpedro1, M J Barjavel, Z Mamdouh, O Bakouche.   

Abstract

Dehydroepiandrosterone (DHEA) alone, whatever the concentration used, or lipopolysaccharide (LPS) alone at 0.2 ng/ml did not induce the release of interleukin-6 (IL-6) or tumor necrosis factor (TNF) by human monocytes. However DHEA (10[-9] M or 10[-12] M) in association with LPS (0.2 ng/ml) did induce the release of IL-6 and TNF. When human monocytes were activated by 1 microg/ml LPS, both IL-6 and TNF secretions were observed. Monocytes activated by both DHEA (10[-9] M or 1O[-12] M) and LPS (1 microg/ml) secreted IL-6 and TNF at a higher level than that observed for monocytes activated only by LPS (1 microg/ml) alone. DHEA alone, whatever the concentration used, or LPS alone at 0.2 ng/ml did not induce the activation of mitogen-activated protein kinases (MAPkinases) and protein kinase C (PKC) or the expression of c-fos and c-jun. However DHEA (10[-9] M or 10[-12] M) and 0.2 ng/ml LPS together induced the activation of both MAPKinases and PKC and the expression of c-fos and c-jun. Furthermore, the activation of PKC and MAPKinases and the expression of c-fos and c-jun were much greater when human monocytes were activated by both LPS (1 microg/ml) and DHEA (10[-9] M or 10[-12] M) than when the monocytes were activated only by LPS at 1 microg/ml. Therefore, DHEA and LPS displayed a synergistic effect on monocyte activation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9506463     DOI: 10.1089/jir.1998.18.125

Source DB:  PubMed          Journal:  J Interferon Cytokine Res        ISSN: 1079-9907            Impact factor:   2.607


  7 in total

Review 1.  Is there a role for dehydroepiandrosterone replacement in the intensive care population?

Authors:  Ketan K Dhatariya
Journal:  Intensive Care Med       Date:  2003-09-03       Impact factor: 17.440

Review 2.  Neuroendocrine effects of stress on immunity in the elderly: implications for inflammatory disease.

Authors:  Kathi L Heffner
Journal:  Immunol Allergy Clin North Am       Date:  2011-02       Impact factor: 3.479

3.  Lipopolysaccharide enhances the production of vascular endothelial growth factor by human pulp cells in culture.

Authors:  K Matsushita; R Motani; T Sakuta; S Nagaoka; T Matsuyama; K Abeyama; I Maruyama; H Takada; M Torii
Journal:  Infect Immun       Date:  1999-04       Impact factor: 3.441

4.  Dehydroepiandrosterone in systemic lupus erythematosus.

Authors:  Amr H Sawalha; Susan Kovats
Journal:  Curr Rheumatol Rep       Date:  2008-08       Impact factor: 4.592

5.  Preliminary studies on the effect of dehydroepiandrosterone (DHEA) on both constitutive and phytohaemagglutinin (PHA)-inducible IL-6 and IL-2 mRNA expression and cytokine production in human spleen mononuclear cell suspensions in vitro.

Authors:  D G Young; G Skibinski; A Skibinska; J I Mason; K James
Journal:  Clin Exp Immunol       Date:  2001-01       Impact factor: 4.330

Review 6.  Might DHEA be considered a beneficial replacement therapy in the elderly?

Authors:  Alessandro D Genazzani; Chiara Lanzoni; Andrea R Genazzani
Journal:  Drugs Aging       Date:  2007       Impact factor: 3.923

Review 7.  Androgen and Androgen Receptors as Regulators of Monocyte and Macrophage Biology in the Healthy and Diseased Lung.

Authors:  Mireya Becerra-Diaz; Mason Song; Nicola Heller
Journal:  Front Immunol       Date:  2020-08-07       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.